172 related articles for article (PubMed ID: 32954588)
1. Nano, micro particulate and cosmetic delivery systems of polylactic acid: A mini review.
Abu Hajleh MN; Al-Samydai A; Al-Dujaili EAS
J Cosmet Dermatol; 2020 Nov; 19(11):2805-2811. PubMed ID: 32954588
[TBL] [Abstract][Full Text] [Related]
2. PLA micro- and nano-particles.
Lee BK; Yun Y; Park K
Adv Drug Deliv Rev; 2016 Dec; 107():176-191. PubMed ID: 27262925
[TBL] [Abstract][Full Text] [Related]
3. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
[TBL] [Abstract][Full Text] [Related]
5. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
6. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
8. Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines.
Caputo A; Sparnacci K; Ensoli B; Tondelli L
Curr Drug Deliv; 2008 Oct; 5(4):230-42. PubMed ID: 18855591
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.
Delie F; Berton M; Allémann E; Gurny R
Int J Pharm; 2001 Feb; 214(1-2):25-30. PubMed ID: 11282232
[TBL] [Abstract][Full Text] [Related]
10. PLA nano- and microparticles for drug delivery: an overview of the methods of preparation.
Lassalle V; Ferreira ML
Macromol Biosci; 2007 Jun; 7(6):767-83. PubMed ID: 17541922
[TBL] [Abstract][Full Text] [Related]
11. Engineering microenvironment of biodegradable polyester systems for drug stability and release control.
Khaliq NU; Chobisa D; Richard CA; Swinney MR; Yeo Y
Ther Deliv; 2021 Jan; 12(1):37-54. PubMed ID: 33397135
[TBL] [Abstract][Full Text] [Related]
12. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
13. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable microspheres for vitreoretinal drug delivery.
Herrero-Vanrell R; Refojo MF
Adv Drug Deliv Rev; 2001 Oct; 52(1):5-16. PubMed ID: 11672871
[TBL] [Abstract][Full Text] [Related]
15. Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer.
Rahimian S; Fransen MF; Kleinovink JW; Amidi M; Ossendorp F; Hennink WE
Curr Pharm Des; 2015; 21(29):4201-16. PubMed ID: 26323429
[TBL] [Abstract][Full Text] [Related]
16. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
17. Use of polylactic acid for the preparation of microparticulate drug delivery systems.
Conti B; Pavanetto F; Genta I
J Microencapsul; 1992; 9(2):153-66. PubMed ID: 1593398
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable polymers for ocular drug delivery.
Kimura H; Ogura Y
Ophthalmologica; 2001; 215(3):143-55. PubMed ID: 11340382
[TBL] [Abstract][Full Text] [Related]
19. Design of biodegradable particles for protein delivery.
Vila A; Sánchez A; Tobío M; Calvo P; Alonso MJ
J Control Release; 2002 Jan; 78(1-3):15-24. PubMed ID: 11772445
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
Hyon SH
Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
